S.C.-Centrul De Cercetare Şi Prelucrare A Plantelor Medicinale "Plantavorel" S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S.C.-Centrul De Cercetare Şi Prelucrare A Plantelor Medicinale "Plantavorel" S.A.filedCriticalS.C.-Centrul De Cercetare Şi Prelucrare A Plantelor Medicinale "Plantavorel" S.A.
Priority to RO93-01298ApriorityCriticalpatent/RO115597B1/en
Publication of RO115597B1publicationCriticalpatent/RO115597B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
According to the invention, the tablets comprise 0.715 parts of acetylsalicylic acid, 0.071 parts of an extract obtained from Symphytum officinale and Calendula officinalis containing at least 0.6% total flavonosides expressed in rutoside, 0.186 parts of starch and 0.028 parts of talcum, all the parts being parts by weight.
Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura